These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Exposure to pyrithiamine increases β-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain. Zhao J; Sun X; Yu Z; Pan X; Gu F; Chen J; Dong W; Zhao L; Zhong C Neurotox Res; 2011 May; 19(4):575-83. PubMed ID: 20567953 [TBL] [Abstract][Full Text] [Related]
84. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8). Porquet D; Andrés-Benito P; Griñán-Ferré C; Camins A; Ferrer I; Canudas AM; Del Valle J; Pallàs M Age (Dordr); 2015 Feb; 37(1):9747. PubMed ID: 25663420 [TBL] [Abstract][Full Text] [Related]
85. The impact of tau hyperphosphorylation at Ser Majd S; Power JHT; Koblar SA; Grantham HJM IBRO Rep; 2017 Jun; 2():1-13. PubMed ID: 30135928 [TBL] [Abstract][Full Text] [Related]
86. Bip enhanced the association of GSK-3β with tau during ER stress both in vivo and in vitro. Liu ZC; Fu ZQ; Song J; Zhang JY; Wei YP; Chu J; Han L; Qu N; Wang JZ; Tian Q J Alzheimers Dis; 2012; 29(4):727-40. PubMed ID: 22460328 [TBL] [Abstract][Full Text] [Related]
87. Eriodictyol ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via vitamin D receptor-mediated Nrf2 activation. Li L; Li WJ; Zheng XR; Liu QL; Du Q; Lai YJ; Liu SQ Mol Med; 2022 Jan; 28(1):11. PubMed ID: 35093024 [TBL] [Abstract][Full Text] [Related]
88. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. Liu F; Iqbal K; Grundke-Iqbal I; Gong CX FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894 [TBL] [Abstract][Full Text] [Related]
89. Stimulation of EphB2 attenuates tau phosphorylation through PI3K/Akt-mediated inactivation of glycogen synthase kinase-3β. Jiang J; Wang ZH; Qu M; Gao D; Liu XP; Zhu LQ; Wang JZ Sci Rep; 2015 Jun; 5():11765. PubMed ID: 26119563 [TBL] [Abstract][Full Text] [Related]
90. Grape seed proanthocyanidins ameliorate neuronal oxidative damage by inhibiting GSK-3β-dependent mitochondrial permeability transition pore opening in an experimental model of sporadic Alzheimer's disease. Sun Q; Jia N; Li X; Yang J; Chen G Aging (Albany NY); 2019 Jun; 11(12):4107-4124. PubMed ID: 31232699 [TBL] [Abstract][Full Text] [Related]
91. The protective underlying mechanisms of Schisandrin on SH-SY5Y cell model of Alzheimer's disease. Zhao ZY; Zhang YQ; Zhang YH; Wei XZ; Wang H; Zhang M; Yang ZJ; Zhang CH J Toxicol Environ Health A; 2019; 82(19):1019-1026. PubMed ID: 31739764 [TBL] [Abstract][Full Text] [Related]
92. Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice. Zang C; Liu H; Shang J; Yang H; Wang L; Sheng C; Zhang Z; Bao X; Yu Y; Yao X; Zhang D Phytomedicine; 2021 Dec; 93():153780. PubMed ID: 34607163 [TBL] [Abstract][Full Text] [Related]
93. A Unique GSK-3β inhibitor B10 Has a Direct Effect on Aβ, Targets Tau and Metal Dyshomeostasis, and Promotes Neuronal Neurite Outgrowth. Shi XL; Yan N; Cui YJ; Liu ZP Cells; 2020 Mar; 9(3):. PubMed ID: 32155989 [TBL] [Abstract][Full Text] [Related]
94. Radix Rehmanniae Praeparata (Shu Dihuang) exerts neuroprotective effects on ICV-STZ-induced Alzheimer's disease mice through modulation of INSR/IRS-1/AKT/GSK-3β signaling pathway and intestinal microbiota. Su Y; Liu N; Sun R; Ma J; Li Z; Wang P; Ma H; Sun Y; Song J; Zhang Z Front Pharmacol; 2023; 14():1115387. PubMed ID: 36843923 [TBL] [Abstract][Full Text] [Related]
95. MiR-21 attenuates apoptosis-triggered by amyloid-β via modulating PDCD4/ PI3K/AKT/GSK-3β pathway in SH-SY5Y cells. Feng MG; Liu CF; Chen L; Feng WB; Liu M; Hai H; Lu JM Biomed Pharmacother; 2018 May; 101():1003-1007. PubMed ID: 29635890 [TBL] [Abstract][Full Text] [Related]
96. In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3beta in neuronal apoptosis: links to tau phosphorylation. Elyaman W; Terro F; Wong NS; Hugon J Eur J Neurosci; 2002 Feb; 15(4):651-60. PubMed ID: 11886446 [TBL] [Abstract][Full Text] [Related]
97. Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3β/Tau pathway. Shi L; Zhang R; Li T; Han X; Yuan N; Jiang L; Zhou H; Xu S Aging (Albany NY); 2020 Dec; 13(3):4590-4604. PubMed ID: 33406505 [TBL] [Abstract][Full Text] [Related]
98. The potential of targeting microRNA-23b-3p signaling in Alzheimer's disease: opinions on recent findings. Wang C; Cai Z; Li Z; Liu R Front Pharmacol; 2023; 14():1245352. PubMed ID: 37502212 [No Abstract] [Full Text] [Related]
99. MicroRNA-455-3P as a peripheral biomarker and therapeutic target for mild cognitive impairment and Alzheimer's disease. Islam MA; Sultana OF; Bandari M; Kshirsagar S; Manna PR; Reddy PH Ageing Res Rev; 2024 Sep; 100():102459. PubMed ID: 39153602 [TBL] [Abstract][Full Text] [Related]
100. Luo M; Pang Y; Li J; Yi L; Wu B; Tian Q; He Y; Wang M; Xia L; He G; Song W; Du Y; Dong Z Acta Pharm Sin B; 2024 Feb; 14(2):635-652. PubMed ID: 38322333 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]